We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

XHLD:NASDAQTEN Holdings, Inc. Analysis

Data as of 2026-08-02 - not real-time

$1.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

TEN Holdings is trading at $1.00, essentially at its 52‑week low, with the 20‑day SMA (≈1.85) sitting above the 50‑day SMA (≈1.58) but still well below the 200‑day SMA (≈2.03), indicating a short‑term bounce within a longer‑term downtrend. Technical indicators show an RSI of 27, suggesting the stock is oversold, while the MACD line sits below its signal line, delivering a bearish histogram. Volatility is extreme at 146% over the past 30 days and a beta of 2.5 points to pronounced price swings, compounded by a decreasing volume trend and thin liquidity (average volume ~267k versus daily volume ~226k). The market sentiment index reads “Extreme Greed,” yet the stock’s fundamentals remain weak: $3.2 M in revenue growing 15% YoY, a gross margin of 75% but an operating margin of –3.3% and negative cash flows. The company recently raised $7.5 M in a follow‑on offering at $1.00 per share, bolstering cash modestly against $3.5 M of debt and a debt‑to‑equity ratio over 200. Forward EPS of $1.65 hints at potential earnings recovery, but current earnings are –$6.63 with a PE of 0, and the balance sheet is strained.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • RSI in oversold territory suggests limited upside
  • Bearish MACD histogram confirms short‑term weakness
  • Decreasing volume and high beta increase price instability

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Recent $7.5 M capital raise improves cash position
  • Forward EPS of $1.65 indicates potential earnings recovery
  • Extreme greed market sentiment may support price appreciation

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Hybrid event platform market growth offers revenue upside
  • Revenue growth of 15% YoY despite current losses
  • Potential debt reduction and operational scaling with new capital

Key Metrics & Analysis

Financial Health

Revenue Growth15.40%
P/E Ratio0.6
ROE-534.23%
ROA-76.61%
Debt/Equity210.77
P/B Ratio2.4
Op. Cash Flow$-4382000
Free Cash Flow$-9023375
Industry P/E15.7

Technical Analysis

TrendNeutral
RSI27.6
Support$0.98
Resistance$2.30
MA 20$1.85
MA 50$1.58
MA 200$2.03
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta2.51
Volatility146.39%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.